Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis
Clinical trial NCT02905331 · COMPLETED
Trial details
- NCT number
- NCT02905331
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-28
- Primary completion
- 2018-02-06
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.